Deferred Acquisition Consideration (Tables)

9 Months Ended

Sep. 30, 2022

Schedule of Changes in Contingent Deferred Acquisition Consideration

The following table presents changes in contingent deferred acquisition consideration, which is measured at fair value on a recurring basis using significant unobservable inputs, and a reconciliation to the amounts reported on the balance sheets as of September 30, 2022 and December 31, 2021:


	September 30, 2022		December 31, 2021
Beginning balance of contingent payments	$	222,369	$	17,847
Payments	(71,865)		(12,431)
Adjustment to deferred acquisition consideration (1)	(13,793)		18,721
Additions (2)	24,594		198,937
Currency Translation Adjustment	(1,576)		—
Other	(140)		(705)
Ending balance of contingent payments (3)	$	159,589	$	222,369

(1) Adjustment to deferred acquisition consideration contains fair value changes from the Company’s initial estimates of deferred acquisition payments. Adjustment to deferred acquisition consideration is recorded within Office and general expenses on the Unaudited Condensed Consolidated Statements of Operations.

(2) In 2021, approximately $61,000 of additions represent deferred acquisition consideration acquired in connection with the acquisition of MDC. Approximately $136,000 of additions represent deferred acquisition consideration acquired in connection with the purchases of noncontrolling interests. See Note 3 of the Notes included herein for additional information related to the purchases of Concentric, Targeted Victory, and Instrument. In 2022, approximately 22,014 of additions represent deferred acquisition consideration acquired in connection with the acquisitions of BNG, Apollo, and PEP Group. See Note 3 of the Notes included herein for additional information related to these purchases.

(3) As of September 30, 2022, approximately, $42,356 of the deferred acquisition consideration is expected to be settled in the Company’s in Class A Common Stock.